Loose Christopher R. 4/A
4/A · Frequency Therapeutics, Inc. · Filed Jul 12, 2023
Insider Transaction Report
Form 4/AAmended
Loose Christopher R.
Chief Scientific Officer
Transactions
- Sale
Common Stock
2023-07-06$0.34/sh−1,384$471→ 198,666 total - Exercise/Conversion
Restricted Stock Unit
2023-07-04−150,000→ 0 total→ Common Stock (150,000 underlying) - Exercise/Conversion
Common Stock
2023-07-04+150,000→ 200,050 total
Footnotes (4)
- [F1]Each Restricted Stock Unit represents a contingent right to receive one share of Issuer common stock.
- [F2]Represents a portion of the shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units pursuant to a Rule 10b5-1 trading plan entered into on March 22, 2022 and does not represent discretionary trades by the Reporting Person.
- [F3]This transaction was executed in multiple trades through a broker-dealer at prices ranging from $0.33 to $0.35. The price reported in this column reflects the weighted average sales price. Upon request, the reporting person will provide to the SEC staff full information regarding the number of shares sold at each price.
- [F4]The Restricted Stock Units fully vested on July 4, 2023 and do not have an expiration date.